ArticleScientific reports2024
Deep Ensemble learning and quantum machine learning approach for Alzheimer's disease detection.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- A data-driven and interpretable hybrid quantum-classical model for male infertility risk assessment.Frontiers in medical technology · 2026Article
- Quo Vadis translational neuroscience?Translational neuroscience · 2026Review
- Alzheimer's disease detection using a quantum deep neural network with Haralick feature extraction and simulated annealing optimization.PeerJ. Computer science · 2026Article
- Artificial intelligence techniques for classification of Alzheimer's disease using neuroimaging data: a review.Frontiers in artificial intelligence · 2026Review
- Artificial Intelligence-Enhanced Multi-Algorithm R Shiny Application for Predictive Modeling and Analytics: Case Study of Alzheimer Disease Diagnostics.JMIR aging · 2025Article
- Article
- Cognitive performance classification of older patients using machine learning and electronic medical records.Scientific reports · 2025Article
- Article
- Mathematical proof of the Fisher-EscolàComputational and structural biotechnology journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer disease (AD) is among the most chronic neurodegenerative diseases that threaten global public health. The prevalence of Alzheimer disease and consequently the increased risk of spread all over the world pose a vital threat to human safekeeping. Early diagnosis of AD is a suitable action for timely intervention and medication, which may increase the prognosis and quality of life for affected individuals. Quantum computing provides a more efficient model for different disease classification tasks than classical machine learning approaches. The full potential of quantum computing is not applied to Alzheimer's disease classification tasks as expected. In this study, we proposed an ensemble deep learning model based on quantum machine learning classifiers to classify Alzheimer's disease. The Alzheimer's disease Neuroimaging Initiative I and Alzheimer's disease Neuroimaging Initiative II datasets are merged for the AD disease classification. We combined important features extracted based on the customized version of VGG16 and ResNet50 models from the merged images then feed these features to the Quantum Machine Learning classifier to classify them as non-demented, mild demented, moderate demented, and very mild demented. We evaluate the performance of our model by using six metrics; accuracy, the area under the curve, F1-score, precision, and recall. The result validates that the proposed model outperforms several state-of-the-art methods for detecting Alzheimer's disease by registering an accuracy of 99.89 and 98.37 F1-score.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.